{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:55:37Z","timestamp":1786373737748,"version":"build-2736575974"},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2003,4,23]]},"DOI":"10.1001\/jama.289.16.2073","type":"journal-article","created":{"date-parts":[[2003,4,22]],"date-time":"2003-04-22T21:06:15Z","timestamp":1051045575000},"page":"2073","source":"Crossref","is-referenced-by-count":580,"title":["Principal Results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial"],"prefix":"10.1001","volume":"289","author":[{"given":"Henry R.","family":"Black","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/1357322","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T17:35:25Z","timestamp":1481823325000},"score":1,"resource":{"primary":{"URL":"http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.289.16.2073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4,23]]},"references-count":0,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2003,4,23]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.289.16.2073","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2003,4,23]]}}}